Publications en collaboration avec des chercheurs de National Cancer Center Hospital (34)

2024

  1. Correction to: Explainable artificial intelligence prediction-based model in laparoscopic liver surgery for segments 7 and 8: an international multicenter study (Surgical Endoscopy, (2024), 38, 5, (2411-2422), 10.1007/s00464-024-10681-6)

    Surgical Endoscopy

  2. Explainable artificial intelligence prediction-based model in laparoscopic liver surgery for segments 7 and 8: an international multicenter study

    Surgical Endoscopy

  3. Nivolumab with or without ipilimumab in patients with recurrent or metastatic cervical cancer (CheckMate 358): a phase 1–2, open-label, multicohort trial

    The Lancet Oncology, Vol. 25, Núm. 5, pp. 588-602

  4. Tisotumab Vedotin as Second- or Third-Line Therapy for Recurrent Cervical Cancer

    New England Journal of Medicine, Vol. 391, Núm. 1, pp. 44-55

2023

  1. Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748 (Leukemia, (2022), 36, 7, (1720-1748), 10.1038/s41375-022-01620-2)

    Leukemia

  2. Final results of DESTINY-CRC01 investigating trastuzumab deruxtecan in patients with HER2-expressing metastatic colorectal cancer

    Nature Communications, Vol. 14, Núm. 1

  3. Obinutuzumab Can Be Administered as a 90-minute Short Duration Infusion in Patients with Previously Untreated Follicular Lymphoma: GAZELLE End of Induction Analysis

    HemaSphere

2022

  1. An International Retrospective Observational Study of Liver Functional Deterioration after Repeat Liver Resection for Patients with Hepatocellular Carcinoma

    Cancers, Vol. 14, Núm. 11

  2. Expert Consensus Guidelines: How to safely perform minimally invasive anatomic liver resection

    Journal of Hepato-Biliary-Pancreatic Sciences, Vol. 29, Núm. 1, pp. 16-32

  3. Glissonean approach for hepatic inflow control in minimally invasive anatomic liver resection: A systematic review

    Journal of Hepato-Biliary-Pancreatic Sciences, Vol. 29, Núm. 1, pp. 51-65

  4. Minimally invasive anatomic liver resection: Results of a survey of world experts

    Journal of Hepato-Biliary-Pancreatic Sciences, Vol. 29, Núm. 1, pp. 33-40

  5. Recommended first-line management of brain metastases from melanoma: A multicenter survey of clinical practice

    Radiotherapy and Oncology, Vol. 168, pp. 89-94

  6. The Tokyo 2020 terminology of liver anatomy and resections: Updates of the Brisbane 2000 system

    Journal of Hepato-Biliary-Pancreatic Sciences, Vol. 29, Núm. 1, pp. 6-15

2021

  1. Elective Cancer Surgery in COVID-19-Free Surgical Pathways during the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study

    Journal of Clinical Oncology, Vol. 39, Núm. 1, pp. 66-78

  2. Multicenter propensity score-based study of laparoscopic repeat liver resection for hepatocellular carcinoma: A subgroup analysis of cases with tumors far from major vessels

    Cancers, Vol. 13, Núm. 13

  3. Outcomes from elective colorectal cancer surgery during the SARS-CoV-2 pandemic

    Colorectal Disease, Vol. 23, Núm. 3, pp. 732-749

  4. Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemic

    British Journal of Surgery, Vol. 108, Núm. 1, pp. 88-96

  5. Safety, Efficacy, and Pharmacodynamics of Tremelimumab Plus Durvalumab for Patients With Unresectable Hepatocellular Carcinoma: Randomized Expansion of a Phase I/II Study

    Journal of Clinical Oncology, Vol. 39, Núm. 27, pp. 2991-3001

  6. The patient's perspective on treatment with dacomitinib: Patient-reported outcomes from the Phase III trial ARCHER 1050

    Future Oncology, Vol. 17, Núm. 7, pp. 783-794

  7. Trastuzumab deruxtecan (DS-8201) in patients with HER2-expressing metastatic colorectal cancer (DESTINY-CRC01): a multicentre, open-label, phase 2 trial

    The Lancet Oncology, Vol. 22, Núm. 6, pp. 779-789